Patrick J. Keenan – Director, Chief Counsel and Strategist
Patrick J. Keenan completed his B.A. with honors in 1985 from Stockton College and received his Juris Doctorate in 1988 from Rutgers School of Law. Patrick is also a graduate of the Temple University Academy of Trial Advocacy. He was admitted to the bar in 1988 in Pennsylvania and New Jersey, the U.S. District Courts for the Eastern District of Pennsylvania and New Jersey, and the U.S. Court of Appeals, Third Circuit. Patrick is a Member of the Philadelphia and Pennsylvania Bar Associations; the Philadelphia Trial Lawyers Association; the American Intellectual Property Law Association; and the Association of University Technology Managers, and listed among Pennsylvania Super Lawyers.
Ivan Joseph – Director
Ivan Joseph is a diversified financial professional with over 20 years of broad-based experience. His background includes positions in commercial banking, international investment fund advisory, as well as senior financial and accounting management roles in technology companies, both public and private, serving the healthcare and life sciences segments. His specialty is working with early stage entities and providing financial and strategic management expertise. He is a graduate of Temple University’s Fox School of Business holding a Bachelors’ degree in Finance and Economics and a Master of Business Administration degree in General & Strategic Management.
Mary Schaheen – Chairman of the Board of Directors, Numoda Capital Innovations
Mary Schaheen is an accomplished business executive with deep experience in integration and product commercialization spanning 25 years in business, 15 as a senior executive. Mary has served as the Numoda Corporation CEO since 2000. Since joining Numoda, she has grown Numoda into a global life sciences company and led the creation of affiliate companies Numoda Technologies and Numoda Capital Innovations. Under Mary’s direction, Numoda Corporate Group has begun strategic investing with clients to further their product commercialization goals. Recognized for her expertise in the life sciences industry, Mary has cultivated, with Numoda, over 3000 C-level and senior contacts among life science companies. She lectures extensively, most recently as keynote speaker highlighting exit opportunities, at a private meeting for CEOs of a group of portfolio companies.
Lester Crawford, MD
Dr. Crawford is the former Commissioner of the United States Food and Drug Administration (FDA). Previously, Dr. Crawford was Chair of the Department of Physiology-Pharmacology at the University of Georgia, Administrator of the Food Safety and Inspection Service (USDA) and Deputy Commissioner of FDA. From 1997-2002, he was Director of the Center for Food and Nutrition Policy at Georgetown University and at Virginia Tech. Dr. Crawford also served as Administrator of the Food Safety and Inspection Service (United States Department of Agriculture) from 1987 to 1991 as well as director of the FDA's Center for Veterinary Medicine from 1978 to 1980, and again from 1982 to 1985.
Mr. Schreiber has more than 30 years of investment experience. In addition to being a Chartered Financial Analyst, Mr. Schreiber holds an MBA from Harvard Business School and a Ph.D. from New York University. He is a member of the New York Society of Security Analysts and a member and former president of the Health Care Analyst Group of New York. Mr. Schreiber has led the portfolio management team of the Merrill Lynch Healthcare Fund since 1990. Prior to 1990, he co-managed that fund's predecessor, the Merrill Lynch SCI/TECH Fund.
Philip P. Gerbino, PharmD
Dr. Gerbino serves as the President at Arrow Prescription University of the Centers, Health ATOZ Sciences, (School of Pharmacy) since 1995. Dr. Gerbino is President of University of the Sciences in Philadelphia, which includes the Philadelphia College of Pharmacy, Misher College of Arts and Sciences, the College of Health Sciences, and the College of Graduate Studies. He has been part of the faculty and administration of that institution for over 25 years. Prior to being named President, he served as the Dean of the School of Pharmacy and as Vice President for academic affairs. In addition, he is a national leader in the pharmacy field and has served as the President of the American Pharmaceutical Association in 1990, the President of the APhA Academy of Pharmacy Practice from 1986 to 1987, a Member of the U.S. Pharmacopeial Advisory Panel on Geriatrics, and as the Chair of the Commission for Certification in Geriatric Pharmacy.
Gregory K. Frykman, MD, Cleveland Clinic
Scientific, medical and regulatory expertise in cancer therapies. Medical reviewer for Division of Oncology Drug Products and Center for Biologics at the FDA. Bachelor’s degree in Physics, a Medical Doctorate, Internal Medicine residency and Medical Oncology fellowship at the Johns Hopkins University. Trained in Developmental Therapeutics at the National Cancer Institute. ABIM board certified in Internal Medicine, Hematology and Medical Oncology.
Todd Plott, MD
Involved in 9 different development programs that have received approval by the U.S. Food and Drug Administration (FDA) and other international regulatory agencies. Five of these programs were personally led and supervised by Dr. Plott from initiation through approval. Former CMO at Revance Therapeutics; VP Clinical Research and Regulatory Affairs at Medicis Pharmaceuticals; Director at Schering-Plough.
Stefan Loren, Ph.D., Westwicke Partners
Wall Street experience, both the buy- and sell-sides. Analyst/Portfolio Manager with hedge fund, Perceptive Advisors and MTB investment Advisors in biotech, specialty pharma, life science-tools, health care service and chemistry outsourcing. Managing Director, Legg Mason. His “Select List” picks returned an average 118% upside, and beat the Nasdaq Biotechology and S&P indicies in 6 of 6 years. At Abbott Laboratories Advanced Technologies Division, integrated new technological advances. At Scripps Research Institute, worked with Nobel Laureate K. Barry Sharpless. Received a doctorate in Organic/Pharm. Chemistry from the UC Berkeley and a B.S. degree in Chemistry from UCSD. Featured in Scientific American, Time, Newsweek, Discover as well as other periodicals and journals.